Yahoo Web Search

Search results

1. Outlook Therapeutics, Inc.

   NasdaqCM: OTLK

   7.13

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.80 (-10.14%)

   At close:4:00 PM EDTWed. May 29, 2024

   6.96 -0.17 (-2.38%)

   After hrs:6:42 PM EDTWed. May 29, 2024

   Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	7.80
     High	7.80
     Low	7.11

   • Mkt Cap	166.88M
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	7.93
     52 Wk. Low	4.00
     52 Wk. High	40.60

   More about OTLK

   Related stocks

   • SEEL
     Seelos Therapeutics, Inc.
     SEEL
     1.3300
     -4.32%
   • VTGN
     Vistagen Therapeutics, Inc.
     VTGN
     3.9600
     -2.46%
   • VTVT
     vTv Therapeutics Inc.
     VTVT
     23.75
     -3.69%
   • GHSI
     Guardion Health Sciences, Inc.
     GHSI
     9.04
     -2.67%
   • ITRM
     Iterum Therapeutics plc
     ITRM
     1.2900
     -2.27%

   More on Yahoo Finance

2. finance.yahoo.com › quote › OTLKOutlook Therapeutics, Inc. (OTLK) Stock Price, News, Quote ...

   finance.yahoo.com › quote › OTLK

   • Cached

   Mountain. Loading Chart for OTLK. 9/21 12:03 PM. Previous Close 7.53. Open 7.59. Bid -- Ask -- Day's Range 7.40 - 7.95. 52 Week Range 4.00 - 40.60. Volume 228,601. Avg. Volume 712,092. Market Cap...

3. Top Stories

   • bovnews

     In the current cycle, Outlook Therapeutics Inc (OTLK) Stock is showing signs of growth

     BTIG Research raised the price target for the Outlook Therapeutics Inc (NASDAQ:OTLK) stock from “a Neutral” to “a Buy”. The rating was released on March 27, 2024, according to finviz. The stock was upgraded by CapitalOne,

     11 hours ago

   • Business Insider

     Buy Rating Justified by Outlook Therapeutics’ Advancements and Market Prospects

     Julian Harrison, an analyst from BTIG, maintained the Buy rating on Outlook Therapeutics (OTLK – Research Report). The associated price

     23 hours ago

   • 

     InvestorPlace on MSN.com

     OTLK Stock Earnings: Outlook Therapeutics Misses EPS for Q2 2024

     2 weeks ago

   • Seeking Alpha on MSN.com

     Outlook gets EU approval for Lytenava for wet AMD

     1 day ago

   • Business Insider

     Buy Rating Affirmed for Outlook Therapeutics on Strong EU Prospects and Solid Financial Position

     Douglas Tsao, an analyst from H.C. Wainwright, reiterated the Buy rating on Outlook Therapeutics (OTLK – Research Report ... Capital One Financial also reiterated a Buy rating on the stock with a $25.00 price target. TipRanks tracks over 100,000 ...

     2 weeks ago

   View all

4. www.nasdaq.com › market-activity › stocksOutlook Therapeutics, Inc. Common Stock (OTLK) - Nasdaq

   www.nasdaq.com › market-activity › stocks

   • Cached

   Get the latest information on OTLK, a biotechnology company developing ophthalmic products. See bid and ask prices, earnings surprises, analyst ratings, revenue and more on Nasdaq.

   • 1 Year Target: $40.00
   • Sector: Health Care

   • Exchange: NASDAQ-CM

5. www.marketwatch.com › investing › stockOTLK Stock Price | Outlook Therapeutics Inc ... - MarketWatch

   www.marketwatch.com › investing › stock

   1 day ago · Outlook Therapeutics Inc. (OTLK) is a biotech company developing treatments for eye diseases. Get the latest stock quote, chart, news, earnings, ratings and more on MarketWatch.

6. www.google.com › finance › quoteOutlook Therapeutics Inc (OTLK) Stock Price & News - Google

   www.google.com › finance › quote

   • Cached

   Get the latest Outlook Therapeutics Inc (OTLK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

7. stockanalysis.com › stocks › otlkOutlook Therapeutics, Inc. (OTLK) - Stock Analysis

   stockanalysis.com › stocks › otlk

   • Cached

   1 day ago · According to 9 analysts, the average rating for OTLK stock is "Strong Buy." The 12-month stock price forecast is $46.43, which is an increase of 485.13% from the latest price.

8. seekingalpha.com › symbol › OTLKOutlook Therapeutics, Inc. (OTLK) Stock Price, Quote, News ...

   seekingalpha.com › symbol › OTLK

   • Cached

   OTLK Stock Price. 1D. 5D. 1M. 6M. YTD. 1Y. 5Y. 10Y. MAX. Basic. -73.49% May 2024 Mar 2024 Jan 2024 Nov 2023 Sep 2023 Jul 2023 0 10 20 30 40. 52 Week Range.

9. www.wsj.com › market-data › quotesOTLK | Outlook Therapeutics Inc. Stock Price & News - WSJ

   www.wsj.com › market-data › quotes

   • Cached

   View the latest Outlook Therapeutics Inc. (OTLK) stock price, news, historical charts, analyst ratings and financial information from WSJ.